TNF and psoriasis: To better understand the non-responsiveness in psoriasis, we aimed to uncover the molecular architecture that underlies the responsiveness to biological drugs, focusing on anti-TNF and anti-IL12/IL23, by using GO on the set of previously published biomarkers.